Life Sciences BPO Market: Rise in Demand for Low Cost Drugs and Patent Expirations Boost the Market Growth

Wilmington, Delaware, United States, Transparency Market Research Inc.: According to Transparency Market Research’s latest research report on the global life sciences BPO market for the historical period from 2017 to 2018 and the forecast period from 2019 to 2027, rise in demand for low cost drugs, patent expirations, and uncertain economic conditions have compelled the pharmaceutical players to take support of various outsourcing services. This is projected to drive the global life sciences BPO market during the forecast period.

According to the report, the global life sciences BPO market was valued at ~US$ 214 Bn in 2018 and is anticipated to expand at a CAGR of 7.9% from 2019 to 2027

Technological Advancements in Life Sciences BPO: A Key Driver

In the current market scenario, strategic outsourcing services play an important role in addressing various challenges faced by pharmaceutical companies such as stagnant productivity volume, regulatory changes, pricing pressures, and thinner profit margins

Strategic outsourcing has become an industry norm and offers a range of services from screening and lead identification to toxicology, pre-clinical studies, clinical trials, manufacturing, and marketing. The pharmaceutical outsourcing market, particularly CMOs and CROs, has evolved in the past few years and expected to witness strong growth in the next decade.

Request Sample of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1782

Outsourcing has become a feasible and beneficial business strategy for pharmaceutical, biotechnology, and life sciences industries, enabling transfer of non-core activities to outsourcing partners in order to focus on distribution networks, competitive advantage, future growth, marketing strategies, and issues imperative for survival. Rise in cost of R&D, decline in productivity, and patent expirations boost the growth of the global life sciences BPO market.

Globalization of Drug Development with Shift of Manufacturing Units from High Cost to Low Cost Regions

The continuous changing market dynamics have compelled the pharmaceutical companies to remodel their existing operations. The focus has shifted toward globalization of the drug development process. The global competitive environment has led to streamlining of manufacturing operations, R&D, medical writing, clinical data management, and other processes.

Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=1782

Outsourcing the clinical trial process to contract research units facilitates evaluation of drugs in multiple locations in parallel, thereby producing data, which originates from a large and varied patient pool. This is considered one of the major advantages of research outsourcing.

Hence, globalization coupled with budget restraints has compelled the drug manufacturers to opt for low cost regions for outsourcing their R&D, clinical trials, and data management services. This in turn is anticipated to boost the global life sciences BPO market during the forecast period.

Stringent Regulatory Approval Processes in Different Countries to Hamper Life Sciences BPO Market

Majority of the clinical trials and other research processes are outsourced to various countries simultaneously. These destination countries have different guidelines and regulatory processes related to drugs, filing, and clinical trials.

The conduction of multi-location trials of a single drug in different procedures in different countries poses a challenge to pharmaceutical companies, as these have to follow a completely different procedure in each country. This is considered one of the major challenges for research outsourcing in different countries. Therefore, a company prefers to restrict outsourcing to one destination country.

Make an Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=1782

Life Sciences BPO Market: Competition Landscape

This report profiles major players operating in the global life sciences BPO market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments

The global life sciences BPO market is highly fragmented, with large number of players in the global market and small-scale players in regional markets. The top four to five players hold major share of the global life sciences BPO market.

Prominent players operating in the global life sciences BPO market are

  • IQVIA
  • Laboratory Corporation of America Holdings
  • Syneos Health, Inc.
  • Parexel International Corporation
  • PRA Health Sciences, Inc.
  • Charles River Laboratories International, Inc.
  • WuXi AppTec Co., Ltd.
  • ICON plc
  • Medpace Holdings, Inc.
  • Pharmaceutical Product Development, LLC.

More Trending Reports by Transparency Market Research –

Mobile Hospitals Market: The global mobile hospitals market is projected to expand at a CAGR of ~10% from 2021 to 2031.

Home Rehabilitation Products & Services Market: The global home rehabilitation products & services market was valued at ~US$ 130 Bn in 2020 and is anticipated to expand at a CAGR of ~7% during the forecast period.

Teleradiology Services Market: the global teleradiology services market was valued over US$ 6.4 Bn in 2020. It is anticipated to expand at a CAGR of ~11% from 2021 to 2031.

PACS and RIS Market: The global PACS and RIS market was valued at US$ 2,633.4 Mn in 2018 and in term of Volume 42,874 Units. The market value is anticipated to expand at a CAGR of 5.3% from 2019 to 2027.

Hospital Furniture Market: The hospital furniture market was valued at US$ 9.5 Bn in 2019 and is projected to reach a value of US$ 16.1 Bn by the end of 2030.

Urgent Care Centers Market: The global urgent care centers market was valued at US$ 23.5 Bn in 2018. It is projected to expand at a CAGR of ~5% from 2019 to 2027.

Neonatal Intensive Care Market: The global neonatal intensive care market was valued at US$ 1,511.7 Mn in 2018 and is anticipated to expand at a CAGR of 5.4% from 2019 to 2027

Laboratory Information Systems Market: The global laboratory information systems market is projected to grow at a CAGR of 8.3% from 2022 to 2031. The laboratory information systems market statistics is estimated to attain valuation surpassing US$ 4.9 Bn by 2031.

About Us

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com

Back to news